Largo Reports Q2 2026 Financial Results Reflecting 68% Revenue Growth and Positive Adjusted EBITDA, Despite Raw Material Input Cost Pressures; and Provides Guidance for New Copper-Platinum Group Metal
Go back to Largo Reports Q2 2026 Financial Results Reflecting 68% Revenue Growth and Positive Adjusted EBITDA, Despite Raw Material Input Cost Pressures; and Provides Guidance for New Copper-Platinum Group Metal| BioLargo, Inc. (NASDAQ: LGO) | Delayed: 0.71 --0 (-0%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $0.71 | 52 Week High | $0.60 | |||
| Open | $0.72 | 52 Week Low | $0.25 | |||
| Day High | $0.73 | P/E | N/A | |||
| Day Low | $0.70 | EPS | $0.00 | |||
| Volume | 277,323 | |||||
